|
1
|
Mankia K and Emery P: Preclinical
rheumatoid arthritis: Progress toward prevention. Arthritis
Rheumatol. 68:779–788. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Firestein GS and McInnes IB:
Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Simon TA, Thompson A, Gandhi KK, Hochberg
MC and Suissa S: Incidence of malignancy in adult patients with
rheumatoid arthritis: A meta-analysis. Arthritis Res Ther.
17(212)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Myasoedova E, Crowson CS, Kremers HM,
Therneau TM and Gabriel SE: Is the incidence of rheumatoid
arthritis rising?: Results from olmsted county, minnesota,
1955-2007. Arthritis Rheum. 62:1576–1582. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
McInnes IB and Schett G: Pathogenetic
insights from the treatment of rheumatoid arthritis. Lancet.
389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Burmester GR and Pope JE: Novel treatment
strategies in rheumatoid arthritis. Lancet. 389:2338–2348.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stoffer MA, Schoels MM, Smolen JS, Aletaha
D, Breedveld FC, Burmester G, Bykerk V, Dougados M, Emery P,
Haraoui B, et al: Evidence for treating rheumatoid arthritis to
target: Results of a systematic literature search update. Ann Rheum
Dis. 75:16–22. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nikiphorou E, Norton S, Young A, Carpenter
L, Dixey J, Walsh DA and Kiely P: ERAS and ERAN. Association
between rheumatoid arthritis disease activity, progression of
functional limitation and long-term risk of orthopaedic surgery:
Combined analysis of two prospective cohorts supports EULAR treat
to target DAS thresholds. Ann Rheum Dis. 75:2080–2086.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Aletaha D and Smolen JS: Diagnosis and
management of rheumatoid arthritis: A review. JAMA. 320:1360–1372.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gavrilă BI, Ciofu C and Stoica V:
Biomarkers in rheumatoid arthritis, what is new? J Med Life.
9:144–148. 2016.PubMed/NCBI
|
|
11
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Welten SM, Bastiaansen AJ, de Jong RC, de
Vries MR, Peters EA, Boonstra MC, Sheikh SP, La Monica N,
Kandimalla ER, Quax PH and Nossent AY: Inhibition of 14q32
MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases
neovascularization and blood flow recovery after ischemia. Circ
Res. 115:696–708. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang DW, Qian GB, Jiang MJ, Wang P and
Wang KZ: Inhibition of microRNA-495 suppresses chondrocyte
apoptosis through activation of the NF-κB signaling pathway by
regulating CCL4 in osteoarthritis. Gene Ther. 26:217–229.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D and Chen J: MicroRNA-326 functions
as a tumor suppressor in glioma by targeting the Nin one binding
protein (NOB1). PLoS One. 8(e68469)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Smolen JS, Breedveld FC, Burmester GR,
Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver
S, Schoels M, et al: Treating rheumatoid arthritis to target: 2014
Update of the recommendations of an international task force. Ann
Rheum Dis. 75:3–15. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Perkins JR, Dawes JM, McMahon SB, Bennett
DL, Orengo C and Kohl M: ReadqPCR and NormqPCR: R packages for the
reading, quality checking and normalisation of RT-qPCR
quantification cycle (Cq) data. BMC Genomics.
13(296)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tobón GJ, Youinou P and Saraux A: The
environment, geo-epidemiology, and autoimmune disease: Rheumatoid
arthritis. Autoimmun Rev. 9:A288–A292. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chiu HY, Huang HL, Li CH, Chen HA, Yeh CL,
Chiu SH, Lin WC, Cheng YP, Tsai TF and Ho SY: Increased risk of
chronic kidney disease in rheumatoid arthritis associated with
cardiovascular complications-a national population-based cohort
study. PLoS One. 10(e0136508)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ito H, Kojima M, Nishida K, Matsushita I,
Kojima T, Nakayama T, Endo H, Hirata S, Kaneko Y, Kawahito Y, et
al: Postoperative complications in patients with rheumatoid
arthritis using a biological agent-a systematic review and
meta-analysis. Mod Rheumatol. 25:672–678. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Clark AL, Maruyama S, Sano S, Accorsi A,
Girgenrath M, Walsh K and Naya FJ: miR-410 and miR-495 are
dynamically regulated in diverse cardiomyopathies and their
inhibition attenuates pathological hypertrophy. PLoS One.
11(e0151515)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kefas B, Comeau L, Erdle N, Montgomery E,
Amos S and Purow B: Pyruvate kinase M2 is a target of the
tumor-suppressive microRNA-326 and regulates the survival of glioma
cells. Neuro Oncol. 12:1102–1112. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee S, Yoon DS, Paik S, Lee KM, Jang Y and
Lee JW: microRNA-495 inhibits chondrogenic differentiation in human
mesenchymal stem cells by targeting Sox9. Stem Cells Dev.
23:1798–1808. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tanaka Y: Human mesenchymal stem cells as
a tool for joint repair in rheumatoid arthritis. Clin Exp
Rheumatol. 33 (Suppl 92):S58–S62. 2015.PubMed/NCBI
|
|
25
|
Gao W, Sweeney C, Connolly M, Kennedy A,
Ng CT, McCormick J, Veale DJ and Fearon U: Notch-1 mediates
hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis
Rheum. 64:2104–2113. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang X, Yang Y and Feng Z: Suppression of
microRNA-495 alleviates high-glucose-induced retinal ganglion cell
apoptosis by regulating Notch/PTEN/Akt signaling. Biomed
Pharmacother. 106:923–929. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mao Y, Li L, Liu J, Wang L and Zhou Y:
miR-495 inhibits esophageal squamous cell carcinoma progression by
targeting Akt1. Oncotarget. 7:51223–51236. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Du C, Liu C, Kang J, Zhao G, Ye Z, Huang
S, Li Z, Wu Z and Pei G: MicroRNA miR-326 regulates TH-17
differentiation and is associated with the pathogenesis of multiple
sclerosis. Nat Immunol. 10:1252–1259. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Wernert N, Justen HP, Rothe M, Behrens P,
Dreschers S, Neuhaus T, Florin A, Sachinidis A, Vetter H and Ko Y:
The Ets 1 transcription factor is upregulated during inflammatory
angiogenesis in rheumatoid arthritis. J Mol Med (Berl). 80:258–266.
2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Du W, Yin L, Tong P, Chen J, Zhong Y,
Huang J and Duan S: miR-495 targeting dvl-2 represses the
inflammatory response of ankylosing spondylitis. Am J Transl Res.
11:2742–2753. 2019.PubMed/NCBI
|
|
32
|
Tomofuji T, Yoneda T, Machida T, Ekuni D,
Azuma T, Kataoka K, Maruyama T and Morita M: Micro RNA s as serum
biomarkers for periodontitis. J Clin Periodontol. 43:418–425.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
García-Díaz D F, Pizarro C,
Camacho-Guillén P, Codner E, Soto N and Pérez-Bravo F: Expression
of miR-155, miR-146a, and miR-326 in T1D patients from Chile:
Relationship with autoimmunity and inflammatory markers. Arch
Endocrinol Metab. 62:34–40. 2018.PubMed/NCBI View Article : Google Scholar
|
